Deerfield Management as of Dec. 31, 2016
Portfolio Holdings for Deerfield Management
Deerfield Management holds 101 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Horizon Pharma | 6.0 | $145M | 9.0M | 16.18 | |
| NxStage Medical | 4.6 | $112M | 4.3M | 26.21 | |
| Avexis | 4.4 | $107M | 2.2M | 47.73 | |
| Portola Pharmaceuticals | 4.3 | $104M | 4.7M | 22.44 | |
| Gw Pharmaceuticals Plc ads | 4.3 | $104M | 928k | 111.75 | |
| Mylan Nv | 3.5 | $85M | 2.2M | 38.15 | |
| Horizon Pharma Plc convertible security | 3.2 | $79M | 83M | 0.95 | |
| Aerie Pharmaceuticals | 2.9 | $70M | 1.8M | 37.85 | |
| Array Biopharma Inc note 3.000% 6/0 | 2.6 | $63M | 45M | 1.39 | |
| Dbv Technologies S A (DBVT) | 2.5 | $61M | 1.7M | 35.13 | |
| Vanda Pharmaceuticals (VNDA) | 2.2 | $55M | 3.4M | 15.95 | |
| Nevro (NVRO) | 2.2 | $55M | 751k | 72.66 | |
| Xencor (XNCR) | 2.2 | $53M | 2.0M | 26.32 | |
| Blueprint Medicines (BPMC) | 2.1 | $52M | 1.8M | 28.05 | |
| Endologix Inc note 2.250%12/1 | 1.9 | $46M | 51M | 0.90 | |
| Anthem (ELV) | 1.9 | $46M | 318k | 143.77 | |
| Lannett Company | 1.8 | $44M | 2.0M | 22.05 | |
| Flamel Technologies | 1.7 | $42M | 4.1M | 10.39 | |
| Wright Med Group Inc note 2.000% 2/1 | 1.7 | $42M | 40M | 1.04 | |
| Humana (HUM) | 1.7 | $40M | 198k | 204.03 | |
| Trn 4% 04/01/45 | 1.7 | $40M | 48M | 0.84 | |
| Universal American | 1.6 | $38M | 3.8M | 9.95 | |
| Endologix, Inc. 3.25% 11/01/2020 | 1.4 | $35M | 41M | 0.87 | |
| Centene Corporation (CNC) | 1.4 | $34M | 604k | 56.51 | |
| Isis Pharmaceuticals Inc Del note 1.000%11/1 | 1.4 | $34M | 33M | 1.02 | |
| Healthways Inc note 1.500% 7/0 | 1.3 | $33M | 25M | 1.30 | |
| Aetna | 1.2 | $30M | 242k | 124.01 | |
| Nevro Corp note 1.750% 6/0 | 1.2 | $30M | 28M | 1.07 | |
| Walgreen Boots Alliance (WBA) | 1.2 | $30M | 356k | 82.76 | |
| Molina Healthcare Inc conv | 1.2 | $29M | 25M | 1.14 | |
| eHealth (EHTH) | 1.2 | $28M | 2.6M | 10.65 | |
| Editas Medicine (EDIT) | 1.1 | $28M | 1.7M | 16.23 | |
| Galapagos Nv- (GLPG) | 1.1 | $27M | 423k | 64.19 | |
| Globus Med Inc cl a (GMED) | 1.1 | $26M | 1.0M | 24.81 | |
| Audentes Therapeutics | 1.1 | $26M | 1.4M | 18.27 | |
| Syros Pharmaceuticals | 0.9 | $22M | 1.8M | 12.16 | |
| Ascendis Pharma A S (ASND) | 0.9 | $21M | 1.1M | 20.24 | |
| BioCryst Pharmaceuticals (BCRX) | 0.8 | $21M | 3.2M | 6.33 | |
| Mallinckrodt Pub | 0.8 | $20M | 407k | 49.82 | |
| Epizyme | 0.8 | $19M | 1.6M | 12.10 | |
| Fluidigm Corporation convertible cor | 0.8 | $19M | 28M | 0.69 | |
| Bluebird Bio (BLUE) | 0.8 | $19M | 302k | 61.70 | |
| Myovant Sciences | 0.8 | $19M | 1.5M | 12.44 | |
| Clovis Oncology Inc note 2.500% 9/1 | 0.7 | $17M | 17M | 1.03 | |
| Recro Pharma (SCTL) | 0.7 | $17M | 2.1M | 8.06 | |
| Axogen (AXGN) | 0.7 | $17M | 1.8M | 9.00 | |
| Zimmer Holdings (ZBH) | 0.6 | $16M | 150k | 103.20 | |
| Tesaro | 0.6 | $15M | 112k | 134.48 | |
| Array BioPharma | 0.6 | $15M | 1.7M | 8.79 | |
| Selecta Biosciences (RNAC) | 0.6 | $15M | 853k | 17.15 | |
| Aac Holdings | 0.6 | $14M | 2.0M | 7.24 | |
| Spark Therapeutics | 0.6 | $14M | 283k | 49.90 | |
| Foamix Pharmaceuticals | 0.6 | $14M | 1.2M | 11.10 | |
| Glaukos (GKOS) | 0.6 | $14M | 393k | 34.30 | |
| Kite Pharma | 0.6 | $13M | 298k | 44.84 | |
| Wave Life Sciences (WVE) | 0.5 | $12M | 472k | 26.15 | |
| Adeptus Health Inc-class A | 0.5 | $12M | 1.6M | 7.64 | |
| Cytomx Therapeutics (CTMX) | 0.4 | $10M | 943k | 10.99 | |
| Ionis Pharmaceuticals (IONS) | 0.4 | $10M | 214k | 47.83 | |
| Aclaris Therapeutics (ACRS) | 0.4 | $10M | 375k | 27.14 | |
| Invuity | 0.4 | $9.7M | 1.7M | 5.75 | |
| Nivalis Therapeutics | 0.3 | $8.4M | 3.7M | 2.24 | |
| Oxford Immunotec Global | 0.3 | $7.9M | 529k | 14.95 | |
| Loxo Oncology | 0.3 | $8.1M | 251k | 32.12 | |
| Akari Therapeutics | 0.3 | $8.1M | 1.2M | 7.04 | |
| Keryx Biopharmaceuticals | 0.3 | $7.6M | 1.3M | 5.86 | |
| Aralez Pharmaceuticals | 0.3 | $7.3M | 1.6M | 4.41 | |
| Axovant Sciences | 0.3 | $7.1M | 568k | 12.42 | |
| Five Prime Therapeutics | 0.3 | $6.9M | 138k | 50.11 | |
| EXACT Sciences Corporation (EXAS) | 0.3 | $6.7M | 500k | 13.36 | |
| Alimera Sciences | 0.3 | $6.3M | 5.9M | 1.08 | |
| Advanced Accelerat spon ads each rep 2 ord | 0.2 | $5.6M | 210k | 26.76 | |
| Myokardia | 0.2 | $5.5M | 425k | 12.95 | |
| Ardelyx (ARDX) | 0.2 | $5.3M | 374k | 14.20 | |
| CAS Medical Systems | 0.2 | $5.2M | 3.2M | 1.61 | |
| Ra Pharmaceuticals | 0.2 | $4.9M | 324k | 15.19 | |
| Steadymed | 0.2 | $4.6M | 1.8M | 2.60 | |
| Essa Pharma | 0.2 | $4.6M | 2.1M | 2.19 | |
| Scynexis | 0.1 | $3.3M | 1.0M | 3.19 | |
| Nanostring Technologies (NSTGQ) | 0.1 | $3.1M | 139k | 22.30 | |
| Kempharm | 0.1 | $3.2M | 1.1M | 2.95 | |
| Genocea Biosciences | 0.1 | $2.8M | 687k | 4.12 | |
| Voyager Therapeutics (VYGR) | 0.1 | $3.0M | 235k | 12.74 | |
| Sangamo Biosciences (SGMO) | 0.1 | $2.6M | 838k | 3.05 | |
| pSivida | 0.1 | $2.6M | 1.5M | 1.71 | |
| Proteon Therapeutics | 0.1 | $2.5M | 1.3M | 1.90 | |
| Catabasis Pharmaceuticals | 0.1 | $2.5M | 683k | 3.61 | |
| Global Blood Therapeutics In | 0.1 | $2.5M | 171k | 14.45 | |
| Celldex Therapeutics | 0.1 | $2.2M | 633k | 3.54 | |
| Agile Therapeutics | 0.1 | $2.3M | 398k | 5.70 | |
| Proteostasis Therapeutics In | 0.1 | $2.3M | 186k | 12.26 | |
| BioScrip | 0.1 | $2.1M | 2.0M | 1.04 | |
| Healthways | 0.1 | $1.7M | 76k | 22.75 | |
| Pronai Therapeutics | 0.1 | $1.7M | 1.2M | 1.49 | |
| Paratek Pharmaceuticals | 0.1 | $1.5M | 100k | 15.40 | |
| Neos Therapeutics | 0.1 | $1.3M | 229k | 5.85 | |
| Noveliontherapeuti.. | 0.1 | $1.4M | 171k | 8.42 | |
| Ocera Therapeutics | 0.1 | $1.2M | 573k | 2.10 | |
| Threshold Pharmaceuticals | 0.0 | $969k | 2.2M | 0.44 | |
| Streamline Health Solutions (STRM) | 0.0 | $829k | 663k | 1.25 | |
| Acura Pharmaceuticals (ACUR) | 0.0 | $790k | 1.0M | 0.77 |
